Sort
82,697 grants matching “vaccine development”
Contribution of CD8 T cells in Controlling Tuberculosis
$787,116Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R56 · FY2018 · AI
ANTIBODY EFFECTOR FUNCTION IN PROTECTION AGAINST HIV-1
$787,069Dennis R. Burton · Scripps Research Institute, The · R01 · FY2006 · AI
Immunoprevention and immunosurveillance of human non-viral cancers
$786,933Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · CA
Development of Fully Human mAbs as Anthrax Antitoxins
$786,931Medarex, Inc. · U01 · FY2005 · AI
Chemokine Modulation During SIV Infection & AIDS
$786,852Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
Strategies for inducing bnAbs against QNES by infection with SHIVs
$786,836Shiu-Lok Hu · Rbhs-New Jersey Medical School · P01 · FY2014 · AI
Effects of obesity on the dynamics of Influenza transmission
$786,815Stacey L Schultz-Cherry · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$786,783William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2024 · AI
Genetic Epidemiology of Chagas Disease Progression
$786,702Sarah A. Williams-Blangero · Texas Biomedical Research Institute · R01 · FY2010 · HL
Novel Adenovirus Vaccine Vectors for HIV/SIV
$786,648Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2009 · AI
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
$786,606Karen A Norris · University Of Georgia · R56 · FY2019 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$786,604Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2007 · IP
Antiviral agents directed to novel targets in the adenovirus proteinase
$786,554Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2010 · AI
Identification of Gene Polymorphisms Associated with Infectious Diseases
$786,549Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Non-human primate models of malarial anemia
$786,544Mary R Galinski · Northwestern University At Chicago · P01 · FY2008 · HL
Second-generation Gene Transfer Vector-based Anti-cocaine Vaccines
$786,533Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · DA
Immunological and Physiological Responses to Measles Vaccine
$786,462Diane E Griffin · Johns Hopkins University · R01 · FY2024 · AI
HIV-1 Envelope Glycoproteins
$786,415Joseph G Sodroski · Dana-Farber Cancer Inst · R37 · FY2013 · AI
An infrastructure for cancer virus discovery from next-generation sequencing data
$786,413Matthew L Meyerson · Dana-Farber Cancer Inst · RC2 · FY2010 · CA
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$786,345John M Dye · Geneva Foundation · R01 · FY2018 · AI
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
$786,175University Of Wisconsin Madison · R01 · FY2001 · AI
Systems Biology of Mumps Vaccine Response
$786,112Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2020 · AI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$786,095Christopher B Fox · Access To Advanced Health Institute · R01 · FY2022 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$786,054Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Identification of the Initial Targets of Transmission
$786,043Thomas Hope · Northwestern University At Chicago · R37 · FY2020 · AI